Isaac Aidonidis

ORCID: 0000-0003-0350-803X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Electrochemical Analysis and Applications
  • Cardiac Ischemia and Reperfusion
  • Analytical Methods in Pharmaceuticals
  • Cardiac Arrest and Resuscitation
  • Cardiac, Anesthesia and Surgical Outcomes
  • Congenital heart defects research
  • Neuroscience and Neural Engineering
  • Ion channel regulation and function
  • Heart Failure Treatment and Management
  • Cardiac Fibrosis and Remodeling
  • Neuropeptides and Animal Physiology
  • Heart Rate Variability and Autonomic Control
  • ECG Monitoring and Analysis
  • Pharmacological Effects and Assays
  • Receptor Mechanisms and Signaling
  • Analytical Chemistry and Sensors
  • Lipoproteins and Cardiovascular Health
  • Pleural and Pulmonary Diseases
  • Cardiovascular Function and Risk Factors
  • Hemodynamic Monitoring and Therapy
  • Cerebrovascular and Carotid Artery Diseases

University of Thessaly
2009-2020

University of Salford
2016

University Hospital of Larissa
2012-2014

National and Kapodistrian University of Athens
1994-2009

Heidelberg University
1988-1997

University Hospital Heidelberg
1989

Chirurgische Universitätsklinik Heidelberg
1989

Ranolazine is a relatively novel antiischemic/antianginal compound with antiarrhythmic properties. We investigated its ability to shorten the time conversion of postoperative atrial fibrillation (POAF) when added amiodarone after coronary artery bypass graft (CABG) surgery. In this prospective, randomized, allocation-concealed, single-blind, single-site clinical trial, we enrolled consecutive eligible patients who developed POAF elective on-pump CABG Participants were randomized receive...

10.1177/0003319713477911 article EN Angiology 2013-02-20

Ranolazine is a new anti-ischemic agent approved for chronic angina with additional electrophysiologic properties. The purpose of the present trial was to investigate its effect in preventing postoperative atrial fibrillation (POAF) after on-pump coronary artery bypass graft (CABG) surgery.In current prospective, randomized, (1 active: 2 control), single-blind (outcome assessors), single-centre clinical we recruited consecutive eligible patients scheduled elective CABG. Participants were...

10.2174/157016111106140128123506 article EN Current Vascular Pharmacology 2014-01-31

Background Amiodarone (AMIO) is for many years effectively used to control ventricular rate during atrial fibrillation (AF) and convert it into sinus rhythm. However, due its delayed onset of action, ranolazine (RAN), a new antianginal agent with atrial‐selective electrophysiologic properties, has recently been attempted as add‐on therapy AMIO facilitate AF conversion. Methods To establish the role this combination therapy, we enrolled 173 consecutive patients (68 ± 10 years, 54% male)...

10.1111/pace.13048 article EN Pacing and Clinical Electrophysiology 2017-02-09

Ranolazine (Ran) is a novel anti-ischemic agent with electrophysiologic properties mainly attributed to the inhibition of late Na(+) current and atrial-selective early current. However, there are only limited data regarding its efficacy mechanism action against atrial flutter (Afl) fibrillation (AF) in intact animals. Therefore, we aimed investigate Ran rabbit model inducible tachyarrhythmias elicited by acetylcholine (ACh). Arrhythmias were produced 19 rabbits rapid burst pacing during...

10.1177/1074248412453874 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2012-08-07

Potassium channel openers are known to act on potassium ATP-dependent channels in cardiac tissue. Such agents may exacerbate acceleration of acute ischemia-induced ventricular repolarization and aggravate arrhythmias. To test whether activation K ATP during the healing period myocardial infarction (MI) can still influence electrophysiologic properties type inducible arrhythmias, we investigated effects bimakalim (BIM) sustained tachycardia (VT) 4 days after ligation left anterior descending...

10.1177/1074248409338929 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2009-07-08

The impact of ranolazine, an anti-ishemic agent with antiarrhythmic properties, on paroxysmal atrial fibrillation (PAF) in patients coronary artery disease (CAD) remains unclear. Pacing devices can be useful tools for disclosing even asymptomatic PAF. Purpose this study is to assess the effect ranolazine (AF), CAD, PAF and a dual-chamber pacemaker. We studied 74 PAF, sick sinus syndrome or atrio-ventricular block, treated pacemakers capable detect episodes. total time AF, AF burden, number...

10.4022/jafib.940 article EN PubMed 2014-02-28

Ranolazine (RAN) and nicardipine (NIC) have been studied for their vasorelaxing eff ects but the combination of these agents against adrenergic vasoconstriction has not tested. The present study aimed at investigating ect by two on alpha1-adrenoceptor-mediated contraction isolated rabbit aorta. Aortic rings were mounted isometric tension recording in organ baths containing Krebs-Henseleit solution. Concentration-response curves RAN (10–9 to 10–4 M), NIC 10–5 + (3 × 10–6 M) obtained a...

10.1080/ac.70.2.3073506 article EN Acta Cardiologica 2015-04-01

In 12 open-chest dogs, cardiac sympathetic nervous activity (CSNA) was recorded before and after occlusion of the left anterior descending coronary artery as well during reperfusion ventricular fibrillation (VF). 7 control animals, CSNA did not significantly differ from preocclusion levels when determined 20 min (+3.5 +/- 1.5%, mean SEM) up to 15 following (+1.5 0.6%). However, VF associated with a potential increase in by 106 15.5% (p less than 0.001). The effect lidocaine (6 mg/kg) on tone...

10.1159/000175003 article EN Cardiology 1992-01-01

Progressive electrical alternans followed by conduction block and fibrillatory have been suggested to precede disorganization of atrial flutter (Afl) fibrillation (AF). The purpose the present study was investigate patterns local repolarization in high low right atrium determine site with pronounced propensity action potential during Afl AF.Combination pacing/recording contact monophasic (MAP) catheters were utilized evaluate from upper endocardium 16 pigs. To induce sustained or (AF),...

10.2143/ac.64.1.2034363 article EN Acta Cardiologica 2009-02-20

Ranolazine has been found to prevent ventricular arrhythmias (VAs) during acute myocardial infarction (AMI). This study aimed investigate its efficacy on VAs induced several days post-MI. For this purpose, 13 anesthetized rabbits underwent coronary artery ligation. Ten of these animals that survived AMI were reanesthetized 3 7 later for electrophysiologic testing. An endocardial monophasic action potential combination catheter was placed in the right ventricle simultaneous pacing and...

10.1177/1074248419858113 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2019-06-26

Journal Article Monoclonal antibodies specific for human cardiac myosin: selection, characterization and experimental myocardial infarct imaging Get access E. HOBERG, HOBERG Search other works by this author on: Oxford Academic PubMed Google Scholar M. EISENHUT, EISENHUT *Abteilung für Nuklearmedizin, University of HeidelbergHeidelberg, West Germany HOFMANN, HOFMANN G. SCHULER, SCHULER J. BRACHMANN, BRACHMANN I. AIDONIDIS, AIDONIDIS NACHTKAMP, NACHTKAMP W. KÜBLER, KÜBLER H. A. KATUS European...

10.1093/oxfordjournals.eurheartj.a062504 article EN European Heart Journal 1988-03-01

The effects of i.v. diltiazem (0.25 mg/kg) and verapamil (0.15 were studied in 18 patients with recurrent paroxysmal supraventricular tachycardia (SVT) who underwent serial electrophysiological studies. In 10 extranodal accessory pathways the similar comparable plasma concentrations. SVT was prevented 10/10 cases after 9/10 verapamil, furthermore there as an increase antegrade refractoriness normal AV nodal pathway 22 27%, respectively; conduction remained unchanged both drugs. 8 dual...

10.1159/000176740 article EN Cardiology 1994-01-01

The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4–8 days after myocardial infarction. Recordings from infarcted normal anterior wall left ventricle obtained with an epicardial implanted 'composite' electrode. Bepridil (5 mg/kg) or (0.025 administered i.v. different testing was repeated. Sustained tachycardia prevented significantly slowed 11/12 experiments compared none 9...

10.1159/000174493 article EN Cardiology 1989-01-01

Summary The effects of prenylamine (PNL) and AQ-A 39 on sustained ventricular tachycardia (SVT) were studied by programmed stimulation in conscious dogs 4–10 days after ligation the left anterior descending (LAD) coronary artery. In 8 16 developing SVT control, PNL (3 mg/kg intravenously, i.v.) suppressed in-ducibility slowed rate 6 other animals. a separate group 10 with inducible SVT, (4 abolished elicitation 3 decreased its dogs. Neither drug affected normal conduction significantly, but...

10.1097/00005344-199309000-00009 article EN Journal of Cardiovascular Pharmacology 1993-09-01

The aim of the present study was to investigate effect lidocaine (L) on ventricular tachyarrhythmias with special reference fibrillation (VF). Myocardial infarction (MI) created in 39 dogs by doubly ligating left anterior descending (LAD) coronary artery. All animals surviving (n = 33) were subjected programmed stimulation 7.6 ± 3.2 days later. Local electrical activity recorded from subepicardium wall means a specially designed composite electrode. L (2 and 4 mg/kg i.v.) facilitated...

10.1159/000176739 article EN Cardiology 1994-01-01
Coming Soon ...